2325 — Yunkang Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual income statement for Yunkang, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,200	1,697	3,756	892	712
Cost of Revenue
Gross Profit	656	899	1,308	326	211
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	859	1,239	3,298	944	1,464
Operating Profit	341	458	459	-52.6	-752
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	323	451	443	-86.8	-791
Provision for Income Taxes
Net Income After Taxes	270	372	374	-102	-793
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	255	381	377	-102	-792
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	255	381	377	-102	-792
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.419	0.605	1.11	-0.169	-0.74
Dividends per Share